Understanding the glass ceiling for functional outcome in schizophrenia

American Journal of Psychiatry

Volumn 163, Issue 3, 2006, Pages 356-358

  Carter, Cameron S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGER; EDITORIAL; EMOTION; FEAR; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HAPPINESS; HUMAN; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SOCIAL PROBLEM; TREATMENT OUTCOME; COGNITIVE DEFECT; COGNITIVE THERAPY; FACIAL EXPRESSION; METHODOLOGY; NOTE; OUTCOME ASSESSMENT; PERCEPTION; PSYCHOLOGY; SOCIAL ADAPTATION;

COGNITION DISORDERS; COGNITIVE THERAPY; EMOTIONS; FACIAL EXPRESSION; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); RESEARCH DESIGN; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL ADJUSTMENT; SOCIAL PERCEPTION; TREATMENT OUTCOME;

EID: 33645933905     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.163.3.356     Document Type: Editorial

References (8)

1. Green MF: What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996; 153:321-330
2. Carter CS: Applying new approaches from cognitive neuroscience to enhance drug development for the treatment of impaired cognition in schizophrenia. Schizophr Bull 2005; 31:810-815
3. Jones EG: Cortical development and thalamic pathology in schizophrenia. Schizophr Bull 1997; 23:483-501
4. Andreasen NC, Arndt S, Swayze VW II, Cizadlo T, Flaum M, O'Leary D, Ehrhardt JC, Yuh WTC: Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science 1994; 266:294-298
5. Jones EG: The Thalamus - Revisited. New York, Cambridge University Press (in press)
6. Lewis D, Hashimoto T, Volk D: Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 2005; 6:312-324
7. Hogarty GE, Flesher S, Ulrich R, Carter M, Greenwald D, Pogue-Geile M, Keshavan M, Cooley S, DiBarry A, Garrett A, Parepally H, Zoretich R: Cognitive enhancement therapy for schizophrenia: effects of a 2 year randomized trial on cognition and behavior. Arch Gen Psychiatry 2004; 61:866-876
8. Harvey PD, Green MF, Keefe RS, Velligan DI: Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness. J Clin Psychiatry 2004; 65:361-372